The CRISP Trial: an RCT of risk assessment and decision support to implement risk-stratified colorectal cancer screening in primary care.

CRISP 试验：一项风险评估和决策支持的随机对照试验，旨在在初级保健中实施风险分层结直肠癌筛查。

• 批准号: nhmrc : 1121104
• 负责人: A/Pr Marie Pirotta
• 金额: $ 64.04万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/crisp-trial-an-primary-care/946681
• 关键词: CRISP; Trial; RCT; risk; assessment

There is a mismatch between people’s use of bowel cancer screening tests through faecal occult blood testing or colonoscopy and their individual risk of bowel cancer. Building on the work of our NHMRC Centre for Research Excellence (CRE) on Optimising Colorectal Cancer Screening, this trial will test the effect of an electronic risk assessment tool, implemented in general practice, on use of the most appropriate screening test for bowel cancer based on a person’s risk of developing the condition

人们通过粪便潜血检测或结肠镜检查进行肠癌筛查的情况与其个人患肠癌的风险不匹配。该试验以 NHMRC 卓越研究中心 (CRE) 在优化结直肠癌筛查方面的工作为基础，将测试在一般实践中实施的电子风险评估工具的效果，以及根据个人患肠癌的风险使用最合适的肠癌筛查测试的效果